Drug testing works in two stages: a fast initial screen that flags samples above a set threshold, followed by a more precise confirmatory test if the first result is positive. Most tests look for metabolites, the byproducts your body creates as it breaks down a substance, rather than the drug itself. The whole process is designed to minimize false results while keeping costs manageable, since the expensive confirmatory test only runs on samples that fail the initial screen.
The Two-Stage Testing Process
The first stage uses a technique called immunoassay. Antibodies designed to bind to specific drug metabolites are mixed with your sample. If enough of a target substance is present, the antibodies react and the test registers as positive. This step is fast, often completed within a few hours, and relatively inexpensive. It screens for broad drug classes like opioids, cocaine metabolites, amphetamines, barbiturates, and benzodiazepines all at once.
Immunoassay is good at catching positives, but it casts a wide net. The antibodies sometimes react to substances that are chemically similar to the target drug, which is why a positive screening result is considered “presumptive” rather than final. Any sample that screens positive moves to the second stage.
Confirmatory testing uses chromatography combined with mass spectrometry. This technology physically separates every compound in the sample, then identifies each one by its molecular weight and structure. It can tell the difference between, say, a prescription painkiller and an illegal opioid, or between an over-the-counter cold medicine and methamphetamine. The specificity is extremely high, which is why this second step is considered the gold standard.
What the Test Is Actually Measuring
Every substance on a drug panel has a cutoff concentration, measured in nanograms per milliliter. If the amount in your sample falls below that cutoff, the result is negative, even if trace amounts are technically present. The federal guidelines set these thresholds to distinguish between meaningful drug use and incidental exposure.
For urine, the initial screening cutoff for marijuana metabolites is 50 ng/mL, dropping to 15 ng/mL at the confirmatory stage. Cocaine metabolites screen at 150 ng/mL and confirm at 100 ng/mL. Amphetamines screen at 500 ng/mL and confirm at 250 ng/mL. These numbers matter because they explain why someone who used a substance days ago might still test positive: the question isn’t whether the drug is “in your system” but whether enough metabolite remains to cross a specific numerical line.
Oral fluid (saliva) tests use much lower cutoffs because drug concentrations in saliva are naturally lower than in urine. Marijuana screens at just 4 ng/mL in saliva versus 50 ng/mL in urine. The tradeoff is that saliva tests have a much shorter detection window.
Urine, Hair, Saliva, and Blood
Urine testing is by far the most common format for workplace screening. It offers a middle-ground detection window, typically catching use from the past few days to a few weeks depending on the substance and how frequently someone used it. Marijuana metabolites are stored in fat cells, so heavy, long-term use can produce positive urine results for weeks after the last use. Most other drugs clear urine within two to four days.
Saliva testing is growing in popularity because collection is simple and hard to tamper with, someone just swabs the inside of their cheek. The detection window is short: amphetamines and methamphetamine show up for about 48 hours, cocaine for roughly 36 hours, opioids up to 48 hours, and marijuana for only about 24 hours. The Department of Transportation authorized oral fluid testing as an alternative to urine in 2023, though implementation has been delayed because there aren’t yet enough federally certified labs with approved collection devices.
Hair testing looks back the furthest. After you use a substance, metabolites circulate through your bloodstream and get incorporated into the hair as it grows. Head hair grows about half an inch per month, so a standard 1.5-inch sample covers roughly 90 days of history. Hair tests are particularly useful for detecting patterns of repeated use, but they won’t catch something used in the last week or so because it takes time for new hair growth to emerge from the scalp.
Blood testing is the most invasive and least common for routine screening. It’s typically reserved for situations where current impairment needs to be established, like a workplace accident investigation or a DUI.
Why False Positives Happen
The immunoassay screening step is where false positives occur. Because the antibodies react to chemical shapes rather than exact molecular identities, structurally similar compounds can trigger a positive result. Common over-the-counter medications are known culprits. Dextromethorphan (the “DM” in many cough suppressants) and diphenhydramine (Benadryl) have both been associated with false positives for PCP. Certain prescription medications, including some anti-anxiety drugs and heart medications, have also shown significant associations with false PCP screens.
This is exactly why the two-stage process exists. The confirmatory test using mass spectrometry identifies compounds at the molecular level and effectively eliminates false positives from cross-reactivity. If you’re taking a prescription or over-the-counter medication that might interfere, the confirmatory stage will sort it out.
Rapid point-of-care tests, the cup-style instant tests you might encounter at a clinic or job site, use the same immunoassay technology as lab-based screening. Studies comparing these instant tests against mass spectrometry have found a sensitivity of about 92% and specificity of about 93%, with a false-negative rate around 1.9%. They’re reasonably accurate for a quick read, but any positive result from a rapid test should still be confirmed by a laboratory.
How Labs Catch Tampering
Labs don’t just test for drugs. They also run specimen validity testing to check whether a urine sample is genuinely yours and hasn’t been tampered with. Three measurements are standard: creatinine concentration, specific gravity, and pH.
Normal urine creatinine falls between 20 and 400 mg/dL. A result between 2 and 20 mg/dL is flagged as diluted, meaning someone likely drank excessive fluids before the test. Below 2 mg/dL, the sample is classified as substituted, suggesting it may not be real urine at all. Similarly, normal pH ranges from 4.5 to 8.0. A pH below 3 or above 11 indicates adulteration, meaning something was added to the sample to try to destroy the drug metabolites.
A diluted result typically means you’ll need to retest. A substituted or adulterated sample is treated as a refusal to test in most regulated programs, which carries the same consequences as a positive result.
What Happens After a Positive Result
In regulated industries like transportation, a positive lab result doesn’t go straight to your employer. It first goes to a Medical Review Officer, a licensed physician trained to evaluate whether there’s a legitimate medical explanation. The MRO contacts you directly and confidentially, giving you a chance to provide documentation of a valid prescription or medical condition that could explain the result.
If you have a legitimate prescription for the substance that was detected, the MRO can verify it and report the result to your employer as negative. If there’s no medical explanation, the MRO reports it as a verified positive. This layer of review exists specifically to protect people who are taking legally prescribed medications from being penalized for a lab result that looks concerning out of context.
Not all employers use an MRO. Many private-sector, non-regulated companies send results directly to human resources or a third-party administrator. If you’re in that situation and believe a result is wrong, you generally have the right to request that your sample be sent for confirmatory testing at a different lab, though policies vary by employer and state.
The Standard 5-Panel and Beyond
The most common workplace drug test is the 5-panel, which screens for marijuana, cocaine, opiates (like morphine and codeine), PCP, and amphetamines (including methamphetamine). This is the standard required for all federal employees and federally regulated workers.
Expanded panels add more substances. A 10-panel test typically adds benzodiazepines, barbiturates, methadone, propoxyphene, and methaqualone. Some employers now use panels that specifically test for fentanyl and synthetic opioids, which weren’t reliably caught by older opiate screens because their chemical structure is different enough to slip past the antibodies designed for natural opiates. Extended opiate panels that include oxycodone and fentanyl are becoming increasingly standard as the drug landscape shifts.